we are committed to delivering innovative solutions that drive growth and add value to our clients. With a team of experienced professionals and a passion for excellence.
Key Points: In today’s Recommendation for Industry, we discuss the low risk of monkeypox in the US, and what businesses can do to keep
FDA has been very clear that CBD is not approved for any uses in food or as a dietary supplement, and it has approved
Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves
While the first quarter of 2022 saw fewer FDA food recalls than the previous quarter, the volume of those recalls increased by 274%, resulting
Key Points: In today’s Recommendation for Industry, we discuss the recent monkeypox outbreak. Read more below. In-utero COVID exposure tied to language, motor delays
Key Points: In today’s Recommendation for Industry, we discuss the westward movement of COVID and increase of BA.4 and BA. 5 in the U.S.
Bisphenol A (BPA) is associated with a myriad of negative connotations thanks to a perpetual campaign against the compound. For years, a relatively small
Consumers cite foodborne illness from bacteria such as E. coli, Salmonella and Listeria as their top food safety concern. While the majority of those
Key Points: In today’s Recommendation for Industry, we discuss defending against infectious disease. Read more below. COVID-19 vaccine during pregnancy may protect infants. The
© 2026 The Acheson Group. All rights reserved
